Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of rat ventricle samples from streptozotocin (STZ)-diabetic animals to investigate mitochondrial long-chain free fatty acid export

ABSTRACT: Cardiomyopathy in type 1 diabetic patients is characterized by early onset diastolic and late onset systolic dysfunction. The mechanism underlying development of diastolic and systolic dysfunction in diabetes remains unknown. We used microarrays to detail the ventricle gene expression changes that underly development of diabetic cardiomyopathy. We identified distinct classes of up-regulated genes during this process. Experiment Overall Design: 150g male Wistar rats (Harlan) we injected with 65 mg/kg streptozotocin to induce Type 1 diabetes. Four replicates of Control and Diabetic rat ventricles were removed and frozen at Three time points for total RNA isolation and hybridization on the Affymetrix RG-U34A microarray. The 3 day samples show a baseline for initial diabetic changes in the ventricle. The 28 day samples show changes associated with diastolic dysfunction in diabetes. The 42 day samples show changes associated with both diastolic and systolic dysfunction in type 1 diabetic rat ventricles.

ORGANISM(S): Rattus norvegicus

SUBMITTER: Mohammed Abdul Matlib 

PROVIDER: E-GEOD-4745 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts.

Gerber Lamar K LK   Aronow Bruce J BJ   Matlib Mohammed A MA  

American journal of physiology. Cell physiology 20060719 6

A number of reports indicate that a long-chain free fatty acid export system may be operating in mitochondria. In this study, we sought evidence of its existence in rat heart mitochondria. To determine its potential role, we also sought evidence of its activation or inhibition in streptozotocin (STZ)-induced diabetic rat heart mitochondria. If confirmed, it could be a novel mechanism for regulation of long-chain fatty acid oxidation (FAO) in mitochondria. To obtain evidence of its existence, we  ...[more]

Similar Datasets

Transcriptomics Expression data from Rat ventricles 3 days/28 days/42 days after STZ injection
2006-05-08 | GSE4745 | GEO
Transcriptomics Atorvastatin Reduces β-Adrenergic Dysfunction in Rats with Diabetic Cardiomyopathy
2017-06-27 | E-MTAB-5594 | biostudies-arrayexpress
Transcriptomics USP28 Serves as A Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart [RNA-seq]
2023-10-15 | GSE244904 | GEO
Transcriptomics Transcription profiling of mouse to predict left ventricle systolic dysfunction using gene expression profiling
2009-10-26 | E-GEOD-12413 | biostudies-arrayexpress
Transcriptomics C1q-TNF-Related Protein-9 protects from diabetic cardiomyopathy by alleviating cardiac insulin resistance and inflammation
2023-02-15 | GSE219101 | GEO
Transcriptomics Gene expression profiling on mouse models of dilated cardiomyopathy
2008-05-01 | GSE7746 | GEO
Transcriptomics Ago2 protects against diabetic cardiomyopathy via activating mitochondrial gene translation II
2024-09-27 | GSE242088 | GEO
Other Ago2 protects against diabetic cardiomyopathy via activating mitochondrial gene translation [Ribo-seq]
2024-09-27 | GSE242185 | GEO
Other Ago2 protects against diabetic cardiomyopathy via activating mitochondrial gene translation [Ribosome-seq]
2024-09-27 | GSE242024 | GEO
Transcriptomics Ago2 protects against diabetic cardiomyopathy via activating mitochondrial gene translation [mRNA-seq]
2024-09-27 | GSE241911 | GEO